|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 125.1 SEK | -2.87% |
|
-3.62% | -31.45% |
| 15/05 | Surgical Science Sweden AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 15/04 | Gisli Hennermark to Leave His Position as CEO of Surgical Science Sweden AB | CI |
Surgical Science Sweden AB (publ) reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was SEK 188.24 million compared to SEK 229.08 million a year ago. Net income was SEK 23.79 million compared to SEK 49.82 million a year ago.
Basic earnings per share from continuing operations was SEK 0.47 compared to SEK 0.98 a year ago. Diluted earnings per share from continuing operations was SEK 0.47 compared to SEK 0.98 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -31.45% | 60Cr | |
| -4.94% | 2.96TCr | |
| +49.49% | 998.13Cr | |
| +34.36% | 440.27Cr | |
| -42.11% | 219.26Cr | |
| -9.44% | 160.39Cr | |
| -28.06% | 124.31Cr | |
| -42.92% | 98Cr | |
| +8.65% | 97Cr | |
| -47.18% | 74Cr |
SURGICAL SCIENCE SWEDEN AB 
